🇺🇸 FDA
Patent

US 10738112

Anti-human interleukin-17A monoclonal antibody

granted A61KA61K38/00A61K39/395

Quick answer

US patent 10738112 (Anti-human interleukin-17A monoclonal antibody) held by SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K39/395, A61P, A61P11/06